MAPK4 emerges as a novel therapeutic target for triple-negative breast cancer
Researchers found that MAPK4 gene expression is elevated in a significant subset of triple-negative breast cancers (TNBCs) and that it seems to play a role in TNBC growth.
Materials provided by Baylor College of Medicine. Note: Content may be edited for style and length.
Source link aaaaa